An act to amend the Federal Food, Drug, and Cosmetic Act to give authority to the Secretary of Health and Human Services, acting through the Commissioner of Food and Drugs, to destroy counterfeit devices.
HOUSE REPORTS: No. 116-512 (Comm. on Energy and Commerce). CONGRESSIONAL RECORD, Vol. 166 (2020): Sept. 21, considered and passed House. Dec. 8, considered and passed Senate, amended. Dec. 10, House concurred in Senate amendment.
Document Citations
Citations are generated automatically from bibliographic data
as a convenience and may not be complete or accurate.
Chicago
Office of the Federal Register, National Archives and Records Administration. "Public Law 116 - 304 - Safeguarding Therapeutics Act". Government. U.S. Government Publishing Office, January 5, 2021. https://www.govinfo.gov/app/details/PLAW-116publ304
APA
Office of the Federal Register, National Archives and Records Administration. (2021, January 5). Public Law 116 - 304 - Safeguarding Therapeutics Act. [Government]. U.S. Government Publishing Office. https://www.govinfo.gov/app/details/PLAW-116publ304
MLA
Office of the Federal Register, National Archives and Records Administration. Public Law 116 - 304 - Safeguarding Therapeutics Act. U.S. Government Publishing Office, (5 Jan 2021), https://www.govinfo.gov/app/details/PLAW-116publ304
Bluebook
Safeguarding Therapeutics Act, Pub. L. No. 116-304 (2021), https://www.govinfo.gov/app/details/PLAW-116publ304
